🔎 Trials Near Me

Utama › Leukemia Limfoblastik Akut › Oklahoma

Kajian klinikal Leukemia Limfoblastik Akut di Oklahoma

8 kajian untuk Leukemia Limfoblastik Akut sedang mencari peserta di lokasi di Oklahoma.

Bandar di Oklahoma

Teks kajian rasmi (Bahasa Inggeris)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Hospital Oklahoma City, Oklahoma City
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

  • Board of Regents of the University of Oklahoma Health Sciences Center, Oklahoma City
Mengambil pesertaKajian pemerhatian
1 Day – 17 Years · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT06274788

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

  • Saint Francis Children's Hospital, Tulsa
Mengambil pesertaFasa 2
Umur 1 hingga 18 · Semua jantina · Dikemas kini 16 Jul 2026 · NCT06533748

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

  • Saint Francis Children's Hospital, Tulsa
Mengambil pesertaFasa 4
Umur 1 hingga 18 · Semua jantina · Dikemas kini 14 Jul 2026 · NCT06289673

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Oklahoma Health Science Center, Oklahoma City
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • University of Oklahoma Health Sciences Center, Oklahoma City
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 18 Mei 2026 · NCT01790152

Pilot Imaging Study of Leukemia

  • University of Oklahoma Health Sciences Center, Oklahoma City
Mengambil pesertaFasa 1
Umur 4 hingga 80 · Semua jantina · Dikemas kini 23 Apr 2026 · NCT03633955

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.